Abstract
The capacities to inhibit coumarin 7-hydroxylase activity of human cytochrome P450 2A6 (CYP2A6) by organosulfur compounds were evaluated. Five dialkyl sulfides and five dialkyl disulfides, with alkyl chains from methyl to amyl, were examined. In addition to these chemicals, diallyl sulfide, diallyl disulfide, allyl methyl sulfide, allyln-propyl sulfide, allyl phenyl sulfide, diphenyl sulfide, diphenyl disulfide, difurfuryl disulfide, phenyl cyclopropyl sulfide, 2,2′-dipyridyl disulfide, 4,4′-dipyridyl sulfide, and 4,4′-dipyridyl disulfide were also examined for their capacity to inhibit CYP2A6. The membrane fraction of genetically engineeredEscherichia coli cells expressing CYP2A6 together with NADPH-cytochrome P450 reductase was used as an enzyme source. Dialkyl disulfides inhibited CYP2A6 more strongly than did dialkyl sulfides. Among dialkyl disulfides examined, di-n-propyl disulfide, contained in onion oil, was the most potent competitive inhibitor of CYP2A6, with a Ki value of 1.73 μM. Diallyl disulfide, present in garlic oil, inhibited CYP2A6 activity in a competitive/noncompetitive mixed manner, with theKi value of 2.13 μM. Among all of the organosulfur compounds tested, 4,4′-dipyridyl disulfide was the most potent inhibitor of CYP2A6, with a Ki value of 60 nM, followed by 4,4′-dipyridyl sulfide, with aKi value of 72 nM. These chemicals inhibited CYP2A6 in a competitive manner. The preincubation time did not affect the inhibitory effects of di-n-propyl disulfide, diallyl disulfide, 4,4′-dipyridyl disulfide, and 4,4′-dipyridyl sulfide on CYP2A6, indicating that these chemicals were not mechanism-based inhibitors of CYP2A6. 4,4′-Dipyridyl disulfide also inhibited midazolam 1′-hydroxylase activity of CYP3A4. We discovered 4,4′-dipyridyl disulfide to be a potent and relatively selective inhibitor of CYP2A6.
Footnotes
-
This study was supported in part by a grant-in-aid from the Ministry of Education, Science, Sports and Culture of Japan, by a grant (99-2) from the Organization for Pharmaceutical Safety and Research (OPSR), by grants-in-aid for Cancer Research from the Ministry of Health and Welfare of Japan, and by a fund under a contract with the Environment Agency of Japan.
- Abbreviations used are::
- CYP
- cytochrome P450
- G6P
- glucose 6-phosphate
- HPLC
- high-performance liquid chromatography
- OR
- NADPH-cytochrome P450 reductase
- SM-12502
- (+)-cis-3, 5-dimethyl-2-(3-pyridyl) thiazolin-4-one hydrochloride
- Received January 16, 2001.
- Accepted April 16, 2001.
- The American Society for Pharmacology and Experimental Therapeutics
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|